The Newest Vital Sign (NVS) is Pfizer's latest contribution to the field of clear health communication. It is a rapid health literacy assessment tool with advantages over previously available tests. The NVS can be administered in approximately 3 minutes and is the only such tool available in English and Spanish.
Research conducted by University of Arizona and University of North Carolina, with funding from Pfizer, validated the NVS against the TOHFLA and demonstrated that the assessment could be conducted in approximately three minutes. This research was published in the peer-reviewed journal Annals of Family Medicine (November/December 2005).
Review Quick Assessment of Literacy in Primary Care: The Newest Vital Sign
Next: Health Literacy and the Prescription Drug Experience >>
print
